Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Current Value
$96.981 Year Return
Current Value
$96.981 Year Return
Market Cap
$244.21B
P/E Ratio
20.22
1Y Stock Return
-5.55%
1Y Revenue Growth
8.17%
Dividend Yield
2.72%
Price to Book
5.5
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PG | 40.62% | $402.15B | +14.14% | 2.33% |
ECL | 37.77% | $69.18B | +30.92% | 0.93% |
AZN | 30.37% | $197.82B | -0.75% | 2.33% |
CL | 30.02% | $76.48B | +22.25% | 2.12% |
WWD | 29.71% | $10.19B | +29.97% | 0.44% |
VRTX | 28.99% | $115.38B | +26.28% | 0.00% |
XYL | 28.74% | $29.70B | +21.00% | 1.15% |
DEO | 28.66% | $66.22B | -15.77% | 3.46% |
KMB | 28.38% | $45.22B | +11.57% | 3.58% |
HLN | 27.40% | $42.91B | +13.94% | 1.67% |
LTC | 27.15% | $1.75B | +19.49% | 5.93% |
REGN | 26.37% | $81.82B | -6.79% | 0.00% |
EPC | 26.28% | $1.69B | +0.38% | 1.74% |
GIS | 25.79% | $34.85B | -2.91% | 3.78% |
UL | 25.46% | $143.25B | +21.40% | 3.25% |
MO | 25.28% | $94.67B | +37.05% | 7.07% |
TRS | 25.23% | $1.06B | +9.03% | 0.61% |
BALL | 25.08% | $17.88B | +11.46% | 1.34% |
SPGI | 24.70% | $155.87B | +21.40% | 0.72% |
AEP | 24.25% | $51.50B | +23.91% | 3.71% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TW | 0.01% | $28.66B | +42.39% | 0.29% |
VSCO | -0.01% | $2.85B | +71.64% | 0.00% |
EEX | -0.01% | $964.17M | -8.83% | 0.63% |
DAO | 0.03% | $159.28M | +25.62% | 0.00% |
CDNS | 0.03% | $82.18B | +10.81% | 0.00% |
AGYS | 0.03% | $3.44B | +39.55% | 0.00% |
TSLA | 0.03% | $1.11T | +43.45% | 0.00% |
KALU | 0.03% | $1.29B | +34.50% | 3.84% |
DV | 0.03% | $3.26B | -37.48% | 0.00% |
SMWB | -0.04% | $1.01B | +134.25% | 0.00% |
CGNT | 0.04% | $501.83M | +59.73% | 0.00% |
NXST | -0.04% | $5.07B | +9.28% | 4.16% |
VVV | -0.05% | $4.98B | +11.54% | 0.00% |
WRAP | -0.06% | $62.86M | -49.45% | 0.00% |
PATK | 0.06% | $2.90B | +54.53% | 1.67% |
KNOP | -0.06% | $210.40M | +11.75% | 1.68% |
MGY | -0.06% | $5.36B | +26.87% | 1.90% |
CTRN | 0.06% | $153.27M | -29.99% | 0.00% |
BLDP | -0.07% | $398.23M | -61.89% | 0.00% |
SEVN | -0.07% | $193.74M | +16.70% | 10.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMNN | -31.26% | $10.02M | -22.89% | 0.00% |
CVLT | -25.00% | $7.37B | +136.34% | 0.00% |
FFIV | -23.23% | $13.97B | +44.43% | 0.00% |
HWM | -19.23% | $47.13B | +122.99% | 0.22% |
ROIC | -18.92% | $2.22B | +43.52% | 3.45% |
SOLV | -18.36% | $11.58B | -16.19% | 0.00% |
VRNS | -18.35% | $5.57B | +25.45% | 0.00% |
PLOW | -17.99% | $572.50M | -7.57% | 4.79% |
HLIT | -16.82% | $1.42B | +12.53% | 0.00% |
SEG | -16.57% | $319.72M | +12.41% | 0.00% |
NEO | -16.17% | $1.97B | -19.92% | 0.00% |
CNO | -14.70% | $4.02B | +51.36% | 1.60% |
HSII | -14.22% | $914.74M | +64.66% | 1.35% |
KLIC | -14.09% | $2.46B | -8.18% | 1.75% |
HUSA | -14.01% | $16.69M | -11.56% | 0.00% |
SFM | -13.96% | $14.34B | +254.87% | 0.00% |
FBMS | -13.20% | $1.12B | +38.46% | 2.78% |
RGEN | -13.19% | $7.20B | -18.16% | 0.00% |
NCMI | -12.95% | $641.63M | +63.48% | 0.00% |
FISI | -12.72% | $408.52M | +49.41% | 4.56% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 46.45% | $592.06M | 0.36% |
IYH | 40.36% | $3.19B | 0.39% |
IHE | 40.30% | $596.23M | 0.39% |
XLV | 40.29% | $38.41B | 0.09% |
FHLC | 39.15% | $2.73B | 0.084% |
VHT | 38.71% | $17.06B | 0.1% |
IXJ | 38.35% | $3.89B | 0.41% |
IYK | 35.86% | $1.30B | 0.4% |
XLP | 35.41% | $16.03B | 0.09% |
VDC | 35.17% | $7.09B | 0.1% |
FSTA | 34.52% | $1.20B | 0.084% |
BBH | 32.26% | $397.87M | 0.35% |
KXI | 31.89% | $695.03M | 0.41% |
PINK | 31.27% | $161.15M | 0.5% |
FXH | 30.83% | $1.15B | 0.62% |
SPLV | 29.41% | $8.93B | 0.25% |
IBB | 29.27% | $6.66B | 0.45% |
XPH | 27.81% | $157.87M | 0.35% |
ACWV | 27.75% | $4.24B | 0.2% |
USMV | 27.41% | $23.89B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HFND | 0.02% | $34.86M | 1.22% |
GCC | -0.03% | $133.23M | 0.55% |
SIXG | 0.04% | $569.71M | 0.3% |
AIA | 0.13% | $747.19M | 0.5% |
MNA | 0.19% | $220.85M | 0.77% |
EWD | 0.21% | $335.41M | 0.54% |
PXJ | 0.26% | $42.76M | 0.66% |
URNJ | -0.27% | $283.55M | 0.8% |
BBJP | -0.28% | $11.60B | 0.19% |
JPXN | 0.29% | $181.98M | 0.48% |
OIH | 0.30% | $1.69B | 0.35% |
SFYF | -0.31% | $19.96M | 0.29% |
QTEC | 0.36% | $3.85B | 0.57% |
IXN | -0.38% | $5.14B | 0.41% |
EZA | 0.39% | $291.73M | 0.59% |
AIQ | 0.43% | $2.39B | 0.68% |
FTGC | -0.46% | $2.17B | 1.02% |
VRP | 0.50% | $1.83B | 0.5% |
IMOM | 0.51% | $80.57M | 0.39% |
EWJ | -0.55% | $13.80B | 0.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BILZ | -18.49% | $563.02M | 0.14% |
VIXY | -13.49% | $195.31M | 0.85% |
USDU | -7.52% | $201.97M | 0.5% |
CQQQ | -7.11% | $733.30M | 0.65% |
CXSE | -7.00% | $406.30M | 0.32% |
GSG | -6.74% | $914.42M | 0.75% |
DBC | -6.73% | $1.39B | 0.87% |
EWJV | -6.66% | $258.12M | 0.15% |
EQLS | -6.57% | $76.08M | 1% |
KRBN | -6.56% | $242.47M | 0.85% |
YEAR | -6.51% | $1.13B | 0.25% |
DBB | -6.49% | $126.37M | 0.77% |
PDBC | -6.23% | $4.40B | 0.59% |
GXC | -6.20% | $433.32M | 0.59% |
TPMN | -5.98% | $40.60M | 0.65% |
UUP | -5.90% | $309.25M | 0.77% |
SMH | -5.88% | $23.66B | 0.35% |
USCI | -5.82% | $185.47M | 1.07% |
FBY | -5.82% | $127.69M | 0.99% |
DBE | -5.81% | $50.13M | 0.77% |
Yahoo
RAHWAY, NJ / ACCESSWIRE / November 20, 2024 / The Merck Foundation (Foundation) has announced a new initiative to help advance equitable access to high-quality, culturally responsive care for people with heart conditions in underserved U.S. communities-the ...
Yahoo
We recently published a list of Ken Griffin Stock Portfolio: 10 Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Ken Griffin’s portfolio stocks to buy. One of Wall Street’s Greatest Ken Griffin, the visionary founder of Citadel Investment Group, launched his […]
MarketWatch
Merck & Co. Inc. stock outperforms competitors on strong trading day
MarketWatch
UnitedHealth, Amgen share gains lead Dow's 114-point climb
SeekingAlpha
Absci Corporation has secured key partnerships but lacks advanced assets. Find out why ABSI stock is still a speculative investment despite its AI potential.
Finnhub
November 20, 2024 2:37 pm ET RAHWAY, N.J., Nov. 20, 2024 - The Merck Foundation , a private charitable organization funded by Merck , known as MSD outside of the United States and...
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.